CADue in 1 day · Nov 2, 2026
Employment Development Department
EMS Program funding will be awarded to increase the number of Emergency Medical Technicians (EMTs) in local communities with a particular focus in the inclusion of young adult participants who come from a disadvantaged or underrepresented backgrounds, including experience in the justice system.
The Employment Development Department (EDD), in coordination with the California Labor and Workforce Development Agency (LWDA), announces the availability of up to $8.5 million in Workforce Innovation and Opportunity Act (WIOA) Governor’s Discretionary funds for the Emergency Medical Services (EMS) Program Year 2026-27 (PY 26-27) Solicitation for Proposals (SFP). EMS Program funding will be awarded to increase the number of Emergency Medical Technicians (EMTs) in local communities with a particular focus in the inclusion of young adult participants who come from a disadvantaged or underrepresented backgrounds, including experience in the justice system. The selected pilot sites have designed, developed, and implemented programs incorporating data-driven strategies to increase the number of EMTs in local emergency health services throughout the EMS Corps Rounds 1 and 2. The continued funding intends to maintain meaningful and sustainable industry investment and partnerships, bolster healthcare systems, and continue to develop projects with the best potential to place participants into quality jobs and career pathways leading to self-sufficiency. The goal of EMS Program is to recruit, train, hire, and advance an ethnically and culturally inclusive health and human services workforce, with improved diversity and higher wages, who can service the community they live in with primary life support care and support their community's healthcare system, and fill workforce shortages in emergency medical services. Strong applicants will demonstrate the capability to continue existing collaboration between the Local Emergency Medical Service Authority (LMSA), fire departments, local training providers, and their partners, including labor partners, on implementing cohort training programs to increase ethnic and cultural diversity in the EMS workforce. These efforts should result in strategies that successfully recruit, train, and employ individuals as EMTs in counties across California. In addition to the EMT curriculum, this program must also continue to offer a holistic suite of wrap-around support, case management, and supportive service interventions designed to address the needs of the target populations to support program completion. Applicants must demonstrate the ability to leverage at least 20 percent of their budget with leveraged resources from other sources. Applicants are encouraged to leverage human capital, and utilize other resources to maximize the project's success. Proposals must be received by 11:59 p.m. PT on November 2, 2026. An informational webinar will be held on October 15, 2026, at 1:30 p.m. PT. Pre-registration is required for all attendees. Please register through the following link by October 15, 2026 at 12 p.m. PT: https://us02web.zoom.us/webinar/register/WN_qaI8bbIqQFSYP-wYWWuFSw. The EDD encourages applicants to submit a Notice of Intent to apply by October 16, 2026, at noon PT to WSBSFP3@edd.ca.gov. To view the SFP, visit the EDD Workforce Development Solicitations for Proposals webpage.
$850,000 – $1,250,000Official notice ↗ FederalDue in 3 days · Nov 4, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow (BMF) failure research and/or patient care. Investigator-Initiated Research Award (IIRA) applications may involve translational and clinical research including studies in preclinical models, research with human data and/or anatomical substances, and research with human subjects, as well as correlative studies associated with a clinical trial(s); however, this award mechanism does not support clinical trials. IIRA applications may also support Investigational New Drug (IND)-enabling efforts such as lead compound characterization, and assessments of formulation and stability, absorption, distribution, metabolism and excretion, dose/response and toxicology.
Distinctive Features:
This funding mechanism allows for a partnering Principal Investigator (PI). Only the initiating PI will submit a pre-application, but both PIs will need to submit full applications. The partnering PI application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials.
Amount not specifiedOfficial notice ↗ FederalDue in 3 days · Nov 4, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Bone Marrow Failure Research Program (BMFRP) Resource Development Award (RDA) supports the development of a multiomic atlas generated from well-annotated human bone marrow failure (BMF) samples, with omic data derived from marrow specimens. The resulting dataset should serve as an open-access, durable resource for the BMF research and clinical communities and is expected to facilitate key discoveries that advance the understanding of BMF diseases.
Distinctive Features: The application must include a robust Data Resource Sharing Plan that describes the means and timeline by which the fully developed resource will be made available to the scientific and clinical community.
Amount not specifiedOfficial notice ↗ FederalDue in 3 days · Nov 4, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases.
Distinctive Features:
This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs). Reviewers will assess Principal Investigators (PIs) using distinct review criteria based on their eligibility as an EI or ECI.
Preliminary data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.
Amount not specifiedOfficial notice ↗ FederalDue in 3 days · Nov 4, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Concept Award supports the exploration of highly innovative new concepts or untested theories that address an important problem relevant to reconstructive transplantation. The Concept Award does not support clinical trials.
Distinctive Features:
· Innovation: Innovative research may introduce a new paradigm, challenge existing paradigms, examine existing problems from new perspectives, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative.
· Relevance: Projects should address at least one of the FY26 RTRP Focus Areas.
· Preliminary Data: Presentation of preliminary data is not allowed; however, applications should demonstrate the ability to achieve interpretable results. A rationale for the proposed work must be provided.
· Early-Career Investigators: Early-career investigators are encouraged to apply. Investigators at or above the level of postdoctoral fellow are eligible to apply.
Amount not specifiedOfficial notice ↗ FederalDue in 4 days · Nov 5, 2026
Centers for Disease Control and Prevention - ERA
The NOFO supports CDC"s efforts to protect U.S. residents traveling internationally. The goal is to help U.S. travelers with pre-travel preparation, access to timely health information while traveling, and timely research on health conditions.The project will:Improve access to high quality travel preparation information for both healthcare providers and travelers.Collect health information before, during, and after travel through innovative electronic medical record (EMR), web, and mobile phone applications.Build on this platform to conduct timely research on emerging health threats.This NOFO will also increase the awareness of travel medicine among primary care providers and provide them with appropriate tools in advising international travelers with up-to-date recommendations.
$750,000 – $1,000,000Official notice ↗ FederalDue in 5 days · Nov 6, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research. Research must address at least one of the four FY26 PRP Focus Areas.
Distinctive Features:
· Partnering Principal Investigator (PI) Option: Allows for more than one PI. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI(s) will be identified as Partnering PI(s), with a maximum of two Partnering PIs.
· Preliminary data are required.
· Clinical trials are allowed.
Amount not specifiedOfficial notice ↗ FederalDue in 5 days · Nov 6, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinson’s disease (PD) research for investigators in the early stages of their careers. The FY26 EIRA offers two funding levels, which align to the research career stage of the Principal Investigator (PI). Funding Level 1 (for fellows) requires the investigator to receive guidance from a designated Mentor, whereas Funding Level 2 (for early-career independent investigators) does not. Proposed research must address at least one of the four FY26 PRP Focus Areas.
Distinctive Features:
· The Early Investigator is considered the PI of the application and must exhibit strong potential for and commitment to pursuing a career as an investigator at the forefront of PD research; however, the PI is not required to have previous PD research experience.
· Funding Level 1: Applications must include at least one Mentor appropriate to the proposed research project who has experience in PD research and mentoring, as demonstrated by a record of active funding, recent publications, and successful mentorship. The selected Mentor(s) should also demonstrate a clear commitment to the development of the PI toward independence as a PD researcher. Preliminary data are encouraged but not required.
· Funding Level 2: Mentor not required. Preliminary data are required.
· Clinical trials are not allowed.
Amount not specifiedOfficial notice ↗ FederalDue in 5 days · Nov 6, 2026
National Institutes of Health
This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. This NOFO requests limited competition applications for a 3-year extension of the COPE-AKI clinical trial consortium, which includes three clinical centers (CCs) and one scientific and data research center (SDRC), to fully meet the enrollment targets, complete participant follow-up, and provide resources for data analysis and dissemination of study findings. There is currently no standard of care for patients after hospitalization with acute kidney injury (AKI). Successful completion of the COPE-AKI study will provide key insights that are expected to directly inform improved clinical management strategies and the development of standard of care for Stage 2 and 3 AKI survivors.
Amount not specifiedOfficial notice ↗ FederalDue in 5 days · Nov 6, 2026
Dept of the Army -- Materiel Command
Department of Army:
The Department of War (DoW) announces the Fiscal Year 2027 Defense University Research Instrumentation Program (DURIP). DURIP is designed to improve the capabilities of accredited United States (U.S.) institutions of higher education to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment or instrumentation. For-profit organizations are not eligible for DURIP funding.
$50,000 – $3,000,000Official notice ↗ FederalDue in 5 days · Nov 6, 2026
Office of Naval Research
In accordance with EO 14332, Improving Oversight of Federal Grantmaking, dated 7 August 2025, and EO 14303, Restoring Gold Standard Science, dated 23 May 2025, this Announcement seeks
proposals from universities to purchase equipment and instrumentation in support of research in areas of interest to the DoW, reflecting the basic research priorities for the Department of War and advancing the administration and agency priorities (c.f., OMB memo M-25-34 “Fiscal Year 2027 Administration Research and Development Budget Priorities and Cross-Cutting Actions”).
DoW interests include the areas of research supported by the Army Research Office (ARO), the Office of Naval Research (ONR), and the Air Force Office of Scientific Research (AFOSR).
A central purpose of the DURIP is to provide equipment and instrumentation to enhance research related education in areas of interest and priority to the DoW. Therefore, your proposal must address the impact of the equipment or instrumentation on your institution’s ability to educate students through research in disciplines important to DoW missions.
$50,000 – $3,000,000Official notice ↗ FederalDue in 5 days · Nov 6, 2026
Air Force Office of Scientific Research
The Department of Defense (DoD) announces the Fiscal Year 2027 Defense University Research Instrumentation Program (DURIP). DURIP is designed to improve the capabilities of accredited United States (U.S.) institutions of higher education to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment or instrumentation. For-profit organizations are not eligible for DURIP funding.
$50,000 – $7,000,000Official notice ↗ CADue in 8 days · Nov 9, 2026
Employment Development Department
The ETPP grants will be awarded to develop and implement projects that accelerate pathways to employment for populations facing significant employment barriers into high-demand occupations for good-quality jobs. The ETPP will develop skill-based pathways by intregrating education and workforce training programs to align with the specific needs of to serve California’s highest-needs populations.
The ETPP grants will be awarded to develop and implement projects that accelerate pathways to employment for populations facing significant employment barriers into high-demand occupations for good-quality jobs. The ETPP will develop skill-based pathways by integrating education and workforce training programs to align with the specific needs of the state’s strategic industry sectors which will will not only ensure that individuals are connected to good-quality jobs but become better prepared to enter high-demand fields. The ETPP aligns with the California Master Plan for Career Education and the Unified Strategic Workforce Development Plan to help connect California workers to jobs and promote sustainable growth of the state’s economy. Proposals must be received by 11:59 p.m. on November 9, 2026. Two informational webinars will be held on October 20, 2026 at 10:00 a.m. and 2:00 p.m. Pre-registration is required for all participants. Once the SFP releases, please refer to the EDD’s Workforce Development Solicitation for Proposals website for the pre-registration link. After successfully pre-registering, a system-generated email will provide the webinar link. Applicants must demonstrate the ability to leverage a minimum of 20 percent of their budget with funds or services from other sources. The leverage needed for funds is based on the total grant funding requested. Applicants are encouraged to braid funds, leverage human capital, and utilize other resources to maximize the success of the project. Leveraged resources can come from a variety of sources. To view the SFP once it releases, visit the EDD Workforce Development Solicitations for Proposals webpage at https://edd.ca.gov/en/jobs_and_training/wdsfp_workforce_development_solicitations_for_proposals. The EDD encourages applicants to submit a notice of intent to apply by October 23, 2026, at noon PT to WSBSFP3@edd.ca.gov.
$1,000,000 – $2,000,000Official notice ↗ FederalDue in 8 days · Nov 9, 2026
Bureau of International Narcotics-Law Enforcement
The Bureau of International Narcotics and Law Enforcement Affairs (INL) of the U.S. Department of State announce an open competition for organizations to submit applications to carry out a project to develop a software-based weighted, random case-allocation system to prevent selective prosecution of transnational organized crime and money laundering cases. Political interference in the prosecution service remains a barrier to fighting transnational organized crime and achieving other U.S. objectives in Serbia. As requested by the High Prosecutorial Council, the body responsible for oversight of the prosecution service, this grant will reduce political manipulation of prosecutions and improve outcomes in extradition cases and cases involving high-level corruption and transnational criminal organization (TCO) leaders whose activities harm U.S. national security interests through random allocation of cases
$750,000 – $1,100,000Official notice ↗ FederalDue in 8 days · Nov 9, 2026
National Institutes of Health
Applications for a 3-year extension/renewal of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) clinical trial consortium are requested to fully meet the enrollment targets, complete participant follow-up, and finalize data analysis and dissemination of study findings. This Notice of Funding Opportunity (NOFO) invites a Single Source application for the eligible organization, the Scientific and Data Research Center (SDRC) already involved in the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Consortium. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.There is currently no standard of care for patients after hospitalization with acute kidney injury (AKI). Successful completion of the COPE-AKI study will provide key insights that are expected to directly inform improved clinical management strategies and the development of standard of care for Stage 2 and 3 AKI survivors.
Amount not specifiedOfficial notice ↗ FederalDue in 9 days · Nov 10, 2026
National Institutes of Health
The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without evidence of disease) and create tools, models, and methods that will enable an in-depth study of its variation and composition in relation to host factors and its influence on health and disease.
The purpose of this NOFO is to support small pilot projects that extend the goals of the HVP, including further validating, improving, and complementing existing and newly developed tools from the HVP program by leveraging human specimens collected from the cohorts under the program; samples from animals to promote the refinement, utilization, and translation of these tools to better serve the goals of the HVP program; expanding existing cohorts and/or biospecimen sampling sites for virome characterization; developing tools, assays, and methods to study the human virome; and defining functional interactions between the human virome and host. These pilot projects will expand the HVP consortium, and collaboration across the HVP is expected. Applicants outside the current HVP are encouraged to apply and pilot projects should not overlap with existing HVP efforts (visit the Common Fund website for a list of funded research).
$50,000 – $100,000Official notice ↗ FederalDue in 9 days · Nov 10, 2026
Office of Elementary and Secondary Education
The Employment and Training Administration at the U.S. Department of Labor (DOL) is soliciting applications in support of the administration of the Impact Aid Discretionary Construction Grant Program on behalf of the U.S. Department of Education (ED). The Impact Aid Discretionary Construction Grant Program provides grants to eligible Impact Aid Local Educational Agencies (LEAs) to assist in addressing their school facility emergency and modernization needs. This competition is limited to emergency grants that meet the absolute priority and other requirements in this notice. The competition uses existing statutory authority and appropriated funds to address urgent school facility needs in federally connected communities while promoting responsible stewardship of taxpayer dollars.
$400,000 – $8,000,000Official notice ↗ FederalDue in 9 days · Nov 10, 2026
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for emerging and chronic infections. The CTEUs design and implement clinical trials and studies, while the NCC provides the administrative and operational framework for a collaborative, integrated network and engages with experts in the field to solicit and generate clinical trial concepts. The NCC and CTEUs will collaboratively create opportunities to advance investigators early in their careers and those new to the field.
Amount not specifiedOfficial notice ↗ FederalDue in 9 days · Nov 10, 2026
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrated CRN. The CRN will comprise four centers: the Scientific Leadership Center (SLC), the Clinical Operations Center (COC), the Laboratory Center (LC), and the Statistics and Data Coordination Center (SDCC).
Amount not specifiedOfficial notice ↗ FederalDue in 9 days · Nov 10, 2026
National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research. The NOFO solicits R61 applications for early-stage projects proposing proof-of-concept/pilot studies to test the technical feasibility of the proposed method, tool, assay, platform, or instrument. Technologies proposed for development may have potential for widespread applicability but must be focused for this program on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
FederalDue in 9 days · Nov 10, 2026
National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens used for basic, clinical, or epidemiological cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous technical validation to encourage adoption by the research community. Well-suited applications must propose the development of technologies that offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, epidemiology. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
FederalDue in 9 days · Nov 10, 2026
National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of spinal cord injury (SCI).
Distinctive Features: This funding opportunity contains an Early-Career Partnership Option, which allows for two Principal Investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the Initiating PI will submit a pre-application, but all PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Applications to this funding opportunity must name at least two spinal cord injury (SCI) community partners (e.g., SCI Lived-Experience Consultants, representatives of community-based organizations) who will provide advice and consultation throughout the planning and implementation of the research project.
Amount not specifiedOfficial notice ↗ FederalDue in 11 days · Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Translational Research Award (TRA) supports translational research that will accelerate the movement of promising ideas in spinal cord injury (SCI) research into clinical applications.
Distinctive Features:
• This funding opportunity contains an Early-Career Partnership Option, which allows for two principal investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
• Applications to this funding opportunity must name at least one SCI community partner (e.g., SCI Lived-Experience Consultant, representative of community-based organizations) who will provide advice and consultation throughout the planning and implementation of the research project.
Amount not specifiedOfficial notice ↗ 
Grant Retriever